# THEOPHYLLINE

NDC: 69315-227
Generic name: THEOPHYLLINE
Labeler / Manufacturer: Leading Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20230515

FDA application: ANDA214950

## Active ingredients

- THEOPHYLLINE: 450 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69315-227"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69315-227
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac490ebf-24e1-47c4-a932-ad4dcafe7aad